Literature DB >> 27784037

Deconstructing Pretest Risk Enrichment to Optimize Prediction of Psychosis in Individuals at Clinical High Risk.

Paolo Fusar-Poli1, Grazia Rutigliano2, Daniel Stahl3, André Schmidt3, Valentina Ramella-Cravaro4, Shetty Hitesh5, Philip McGuire3.   

Abstract

IMPORTANCE: Pretest risk estimation is routinely used in clinical medicine to inform further diagnostic testing in individuals with suspected diseases. To our knowledge, the overall characteristics and specific determinants of pretest risk of psychosis onset in individuals undergoing clinical high risk (CHR) assessment are unknown.
OBJECTIVES: To investigate the characteristics and determinants of pretest risk of psychosis onset in individuals undergoing CHR assessment and to develop and externally validate a pretest risk stratification model. DESIGN, SETTING, AND PARTICIPANTS: Clinical register-based cohort study. Individuals were drawn from electronic, real-world, real-time clinical records relating to routine mental health care of CHR services in South London and the Maudsley National Health Service Trust in London, United Kingdom. The study included nonpsychotic individuals referred on suspicion of psychosis risk and assessed by the Outreach and Support in South London CHR service from 2002 to 2015. Model development and validation was performed with machine-learning methods based on Least Absolute Shrinkage and Selection Operator for Cox proportional hazards model. MAIN OUTCOMES AND MEASURES: Pretest risk of psychosis onset in individuals undergoing CHR assessment. Predictors included age, sex, age × sex interaction, race/ethnicity, socioeconomic status, marital status, referral source, and referral year.
RESULTS: A total of 710 nonpsychotic individuals undergoing CHR assessment were included. The mean age was 23 years. Three hundred ninety-nine individuals were men (56%), their race/ethnicity was heterogenous, and they were referred from a variety of sources. The cumulative 6-year pretest risk of psychosis was 14.55% (95% CI, 11.71% to 17.99%), confirming substantial pretest risk enrichment during the recruitment of individuals undergoing CHR assessment. Race/ethnicity and source of referral were associated with pretest risk enrichment. The predictive model based on these factors was externally validated, showing moderately good discrimination and sufficient calibration. It was used to stratify individuals undergoing CHR assessment into 4 classes of pretest risk (6-year): low, 3.39% (95% CI, 0.96% to 11.56%); moderately low, 11.58% (95% CI, 8.10% to 16.40%); moderately high, 23.69% (95% CI, 16.58% to 33.20%); and high, 53.65% (95% CI, 36.78% to 72.46%). CONCLUSIONS AND RELEVANCE: Significant risk enrichment occurs before individuals are assessed for a suspected CHR state. Race/ethnicity and source of referral are associated with pretest risk enrichment in individuals undergoing CHR assessment. A stratification model can identify individuals at differential pretest risk of psychosis. Identification of these subgroups may inform outreach campaigns and subsequent testing and eventually optimize psychosis prediction.

Entities:  

Mesh:

Year:  2016        PMID: 27784037     DOI: 10.1001/jamapsychiatry.2016.2707

Source DB:  PubMed          Journal:  JAMA Psychiatry        ISSN: 2168-622X            Impact factor:   21.596


  54 in total

1.  Lack of evidence to favor specific preventive interventions in psychosis: a network meta-analysis.

Authors:  Cathy Davies; Andrea Cipriani; John P A Ioannidis; Joaquim Radua; Daniel Stahl; Umberto Provenzani; Philip McGuire; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

2.  Why ultra high risk criteria for psychosis prediction do not work well outside clinical samples and what to do about it.

Authors:  Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548

3.  What Is an Attenuated Psychotic Symptom? On the Importance of the Context.

Authors:  Paolo Fusar-Poli; Andrea Raballo; Josef Parnas
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

4.  Care Pathways Before First Diagnosis of a Psychotic Disorder in Adolescents and Young Adults.

Authors:  Gregory E Simon; Christine Stewart; Enid M Hunkeler; Bobbi Jo Yarborough; Frances Lynch; Karen J Coleman; Arne Beck; Belinda H Operskalski; Robert B Penfold; David S Carrell
Journal:  Am J Psychiatry       Date:  2018-01-24       Impact factor: 18.112

5.  Improving outcomes of first-episode psychosis: an overview.

Authors:  Paolo Fusar-Poli; Patrick D McGorry; John M Kane
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

6.  Development and Validation of a Dynamic Risk Prediction Model to Forecast Psychosis Onset in Patients at Clinical High Risk.

Authors:  Erich Studerus; Katharina Beck; Paolo Fusar-Poli; Anita Riecher-Rössler
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

7.  Considerations for the development and implementation of brief screening tools in the identification of early psychosis.

Authors:  Jason Schiffman
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

8.  Predicting Remission in Subjects at Clinical High Risk for Psychosis Using Mismatch Negativity.

Authors:  Minah Kim; Tak Hyung Lee; Youngwoo Bryan Yoon; Tae Young Lee; Jun Soo Kwon
Journal:  Schizophr Bull       Date:  2018-04-06       Impact factor: 9.306

9.  Lack of Diagnostic Pluripotentiality in Patients at Clinical High Risk for Psychosis: Specificity of Comorbidity Persistence and Search for Pluripotential Subgroups.

Authors:  Scott W Woods; Albert R Powers; Jerome H Taylor; Charlie A Davidson; Jason K Johannesen; Jean Addington; Diana O Perkins; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Thomas H McGlashan
Journal:  Schizophr Bull       Date:  2018-02-15       Impact factor: 9.306

10.  What causes psychosis? An umbrella review of risk and protective factors.

Authors:  Joaquim Radua; Valentina Ramella-Cravaro; John P A Ioannidis; Abraham Reichenberg; Nacharin Phiphopthatsanee; Taha Amir; Hyi Yenn Thoo; Dominic Oliver; Cathy Davies; Craig Morgan; Philip McGuire; Robin M Murray; Paolo Fusar-Poli
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.